Rkl Wealth Management Lowers stake in Henry Schein (HSIC)

Henry Schein (HSIC) : Rkl Wealth Management reduced its stake in Henry Schein by 0.84% during the most recent quarter end. The investment management company now holds a total of 40,257 shares of Henry Schein which is valued at $7,206,406 after selling 340 shares in Henry Schein , the firm said in a disclosure report filed with the SEC on Jul 25, 2016.Henry Schein makes up approximately 3.59% of Rkl Wealth Management’s portfolio.

Other Hedge Funds, Including , Investment House boosted its stake in HSIC in the latest quarter, The investment management firm added 1,150 additional shares and now holds a total of 22,090 shares of Henry Schein which is valued at $3,954,331. Henry Schein makes up approx 0.60% of Investment House’s portfolio.Shinko Asset Management Ltd. reduced its stake in HSIC by selling 400 shares or 20.69% in the most recent quarter. The Hedge Fund company now holds 1,533 shares of HSIC which is valued at $276,952.Curian Capital reduced its stake in HSIC by selling 4,704 shares or 63.46% in the most recent quarter. The Hedge Fund company now holds 2,709 shares of HSIC which is valued at $489,570. Henry Schein makes up approx 0.03% of Curian Capital’s portfolio.

Henry Schein opened for trading at $179.88 and hit $181.27 on the upside on Friday, eventually ending the session at $180.98, with a gain of 0.95% or 1.7 points. The heightened volatility saw the trading volume jump to 3,97,737 shares. Company has a market cap of $14,852 M.

On the company’s financial health, Henry Schein reported $1.41 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.39. The company had revenue of $2712.96 million for the quarter, compared to analysts expectations of $2667.28 million. The company’s revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.28 EPS.

Many Wall Street Analysts have commented on Henry Schein. Company shares were Reiterated by Barrington Research on May 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 188 from a previous price target of $182 .

Henry Schein Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products laboratory products equipment repair services branded and generic pharmaceuticals vaccines surgical products diagnostic tests infection-control products and vitamins among others. The Company’s global technology and value-added services segment provides software technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis e-services practice technology network and hardware services as well as continuing education services for practitioners.

Leave a Reply

Henry Schein - Is it time to Sell?

Top Brokerage Firms are advising their investors on Henry Schein. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.